Exact Mass: 333.059
Exact Mass Matches: 333.059
Found 46 metabolites which its exact mass value is equals to given mass value 333.059
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3-[(2-Chlorobenzylidene)amino]-6H-dibenzo[b,d]pyran-6-one
Robenidine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents Antiprotozoal, coccidiostat for poultry and rabbits Robenidine is a coccidiostat
Robenidine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent CONFIDENCE standard compound; INTERNAL_ID 1193 CONFIDENCE standard compound; INTERNAL_ID 1093
Robenz
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
Boc-(R)-3-AMino-3-(2,3-dichloro-phenyl)-propionic acid
2-amino-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide
2-[3-(4-chlorophenoxy)-5-fluoro-2-methylindol-1-yl]acetic acid
2-TERT-BUTOXYCARBONYLAMINO-3-(3,4-DICHLORO-PHENYL)-PROPIONIC ACID
Boc-(S)-3-Amino-3-(2,3-dichlorophenyl)-propionic acid
boc-(r)-3-amino-3-(2,4-dichloro-phenyl)-propionic acid
3-[(TERT-BUTOXYCARBONYL)AMINO]-3-(3,4-DICHLOROPHENYL)PROPANOIC ACID
6-BROMO-3-PHENYL-3,4,5,6-TETRAHYDRO-2H-[1,2]BIPYRAZINYL-3-YLAMINE
GSK1059615
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
3-BROMO-2-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)-6-FLUOROANILINE
N-(4-TRIFLUOROMETHYL)PHENYL-3-TRIFLUOROMETHYLBENZAMIDE
N-[4-(TRIFLUOROMETHYL)PHENYL]-4-(TRIFLUOROMETHYL)BENZAMIDE
2-[[(2,4-Difluorophenyl)-2-oxiranyl]methyl]-1H-1,2,4-triazole methanesulfonate
2-((E)-5-((Z)-3-methyl-4-phenylbut-3-enylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid
1-(3-Bromo-5-methylpyridin-2-yl)-4-propylpiperazine hydrochloride
2-(3-Bromo-2-oxopropyl)-3-methoxy-1-piperidinecarboxylic acid 2-propenyl ester
boc-(s)-3-amino-3-(2,4-dichloro-phenyl)-propionic acid
N,N-Bis(4-chlorobenzyl)-1H-1,2,3,4-tetraazol-5-amine
4-[1-(2,6-Dichlorobenzyl)-2-Methyl-1h-Imidazol-4-Yl]pyrimidin-2-Amine
N-(4-chloro-2-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine
1-(5-Chloro-2,4-Dimethoxyphenyl)-3-(5-Cyanopyrazin-2-Yl)urea
(2R)-2,3-dihydroxypropyl (1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl phosphate
3-Pyridinecarboxylic acid [2-(2-furanyl)-4-oxo-1-benzopyran-3-yl] ester
N-(4-chloro-2-fluorophenyl)-3-(methoxymethyl)-2-benzofurancarboxamide
2-Chloro-5-methyl-1-oxo-3-phenyl-4-pyrido[1,2-a]benzimidazolecarbonitrile
1-(sn-glycero-3-O-phosphonato)-1D-myo-inositol
An inositol phosphate oxoanion obtained by deprotonation of the free phosphate OH group of 1-(sn-glycero-3-phospho)-1D-myo-inositol; major species at pH 7.3.